IDO1 and ovarian carcinoma: Consistently, IDO1-overexpression ovarian cancer cell-derived EVs increased the endothelial mito-ROS, while IDO1-knockdown ovarian cancer cell-derived EVs suppressed the endothelial mito-ROS (Fig. 7b).